Trial Profile
Phase IIb dose finding study of SER-100 in patients with treatment resistant isolated systolic hypertension
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2016
Price :
$35
*
At a glance
- Drugs SER 100 (Primary)
- Indications Isolated systolic hypertension
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Serodus
- 14 Jan 2016 New trial record